Prosecution Insights
Last updated: October 02, 2026

Examiner: POLAND, CHERIE MICHELLE

Tech Center 3700 • Art Units: 1647 3771 3794 3796

This examiner grants 60% of resolved cases

Analysis

Cherie Michelle Poland is an examiner in Tech Center 3700 and Art Unit 1647. The examiner has 602 resolved cases and an allowance rate of 59.5 percent. This rate indicates a moderate likelihood of success. The median days to allowance is 1308, which serves as a benchmark for the time required to reach a grant. With 602 resolved cases, the data provides a reliable perspective on the examiner's tendencies.

The interview lift for this examiner is 33.3 percent. This is a substantial lift, suggesting that interviews are very effective in this examiner's practice compared to the 59.5 percent baseline. Practitioners should prioritize direct communication to leverage the 33.3 percent lift. The 1308 median days to allowance is a key consideration for the timeline in Art Unit 1647. Given the 602 resolved cases, the 33.3 percent interview lift offers a clear path to improve the 59.5 percent probability of allowance.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

59.5%
Allow Rate
-10.5% vs TC avg
641
Total Applications
+33.3%
Interview Lift
1308
Avg Prosecution Days
Based on 602 resolved cases, 2023–2026

Rejection Statute Breakdown

5.2%
§101 Eligibility
21.2%
§102 Novelty
34.0%
§103 Obviousness
27.2%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
19053129 ASPIRATION CATHETER HAVING DISTAL SIDEWALL OPENING Non-Final OA Covidien LP
18859328 SURGICAL SYSTEM INCLUDING A CORDLESS SURGICAL INSTRUMENT, COMMUNICATION HUB, AND ONE OR MORE CONNECTED DEVICES Non-Final OA COVIDIEN LP
18281949 ROBOTIC REMOTE CENTER OF MOTION WITH ACTIVE PORTAL/TROCAR MANIPULATION Final Rejection Covidien LP
18117691 SURGICAL END EFFECTORS Final Rejection Covidien LP
19201511 LEFT ATRIAL APPENDAGE IMPLANT Non-Final OA BOSTON SCIENTIFIC SCIMED, INC.
19171918 STENT AND ASSOCIATED SYSTEMS AND METHODS Non-Final OA BOSTON SCIENTIFIC SCIMED, INC.
19041187 MEDICAL SYSTEMS AND DEVICES FOR TISSUE MARKING AND/OR REMOVAL AND RELATED METHODS Non-Final OA Boston Scientific Scimed, Inc.
18989240 EMBOLIC PROTECTION DEVICES AND METHODS FOR EMBOLIC PROTECTION Final Rejection Boston Scientific Scimed, Inc.
17983513 UTERINE MANIPULATOR FOR ROBOTIC SURGICAL SYSTEM Non-Final OA Cilag GmbH International
17957923 ADAPTING TISSUE TREATMENT MOTION PARAMETERS BASED ON SITUATIONAL PARAMETERS Final Rejection Cilag GmbH International
19202037 SURGICAL INSTRUMENTS FOR APPLYING MULTIPLE CLIPS Non-Final OA INTUITIVE SURGICAL OPERATIONS, INC.
17376508 END EFFECTOR IDENTIFICATION IN SURGICAL ROBOTIC SYSTEMS Final Rejection DePuy Synthes Products, Inc.
19043654 SYSTEMS AND METHODS FOR PERCUTANEOUS TREATMENT AND DEBRIDEMENT OF INFECTIONS Non-Final OA VANDERBILT UNIVERSITY
18853683 CATHETER INSERTION TOOL Non-Final OA Medtronic, Inc.
18614990 OCCLUSION APPARATUS AND METHODS Non-Final OA Medtronic, Inc.
19050278 Surgical Instrument and Methods of Tissue Repair Non-Final OA Arthrex, Inc.
18710681 LITHOTRIPSY DEVICE FOR BREAKING UP BODY STONES, LITHOTRIPSY SYSTEM, RETROFIT KIT FOR RETROFITTING AN EXISTING LITHOTRIPSY DEVICE, AND METHOD FOR OPERATING A LITHOTRIPSY DEVICE Non-Final OA KARL STORZ SE & Co. KG
18991527 Intravascular Lithoplasty System With Improved Durability, Efficiency and Pressure Output Variability Non-Final OA Cardiovascular Systems, Inc.
18866415 MANAGEMENT OF STORED ANGULAR MOMENTUM IN STALLED INTRAVASCULAR ROTATIONAL DRIVE SHAFTS FOR ATHERECTOMY Final Rejection CARDIOVASCULAR SYSTEMS, INC.
17938490 ROTATIONAL DRIVE SHAFTS AND INTRAVASCULAR MEDICAL DEVICES THEREOF Final Rejection Cardiovascular Systems, Inc.
18669332 LEADLESS PACEMAKER HAVING ATTACHMENT FEATURE Non-Final OA Pacesetter, Inc.
17808325 INTRA-KIDNEY STONE DISRUPTOR Non-Final OA GYRUS ACMI, INC. D/B/A OLYMPUS SURGICAL TECHNOLOGIES AMERICA
18857805 EMBOLIC PROTECTION FOR MITRAL AND TRICUSPID VALVE PROCEDURES Non-Final OA Emboline, Inc.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month